EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MIR27A Gene Polymorphism Modifies the Effect of Common DPYD Gene Variants on Severe Toxicity in Patients with Gastrointestinal Tumors Treated with Fluoropyrimidine-Based Anticancer Therapy

Anna Ikonnikova iD, Denis Fedorinov iD, Dmitry Gryadunov iD, Rustam Heydarov iD, Marina Lyadova, Alexey Moskalenko, Vladimir Mikhailovich iD, Marina Emelyanova iD, Vladimir Lyadov iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25158503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Anna Ikonnikova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences,…. Hauptthemen laut MEDLINE: MicroRNAs, Dihydrouracil Dehydrogenase (NADP), Polymorphism, Single Nucleotide, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Science and Higher Education of the Russian Federation, Ministry of Science and Higher Education of the Russian Federation to the EIMB Center for Precision Genome Editing and Genetic Technologies for Biomedicine und….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To reduce severe fluoropyrimidine-related toxicity, pharmacogenetic guidelines recommend a dose reduction for carriers of four high-risk variants in the DPYD gene (*2A, *13, c.2846A>T, HapB3). The polymorphism in the MIR27A gene has been shown to enhance the predictive value of these variants. Our study aimed to explore whether rs895819 in the MIR27A gene modifies the effect of five common DPYD variants: c.1129-5923C>G (rs75017182, HapB3), c.2194G>A (rs1801160, *6), c.1601G>A (rs1801158, *4), c.496A>G (rs2297595), and c.85T>C (rs1801265, *9A). The study included 370 Caucasian patients with gastrointestinal tumors who received fluoropyrimidine-containing chemotherapy. Genotyping was performed using high-resolution melting analysis. The DPYD*6 allele was associated with overall severe toxicity and neutropenia with an increased risk particularly pronounced in patients carrying the MIR27A variant. All carriers of DPYD*6 exhibited an association with asthenia regardless of their MIR27A status. The increased risk of neutropenia in patients with c.496G was only evident in those co-carrying the MIR27A variant. DPYD*4 was also significantly linked to neutropenia risk in co-carriers of the MIR27A variant. Thus, we have demonstrated the predictive value of the *6, *4, and c.496G alleles of the DPYD gene, considering the modifying effect of the MIR27A polymorphism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDihydrouracil Dehydrogenase (NADP)Polymorphism, Single NucleotideGastrointestinal NeoplasmsHumansMaleFemaleMiddle AgedAgedAdultGenotypeFluorouracilAllelesAged, 80 and over

Stichwörter der Autor:innen

DPYDMIR27Achemotherapydihydropyrimidine dehydrogenasefluoropyrimidinesmiR-27aoncologypersonalized medicinepharmacogeneticstoxicity

Substanzen

MicroRNAsDihydrouracil Dehydrogenase (NADP)MIRN27 microRNA, humanFluorouracil

Autor:innen und Institutionen

  • Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.
  • Oncology Center No. 1, Moscow City Hospital Named after S. S. Yudin, Moscow Healthcare Department, 117152 Moscow, Russia.
  • Department of Oncology and Palliative Medicine Named after Academician A.I. Savitsky, Russian Medical Academy of Continuous Professional Education, 123242 Moscow, Russia.
  • Laboratory of Biological Microchips, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.
  • Department of Oncology, Novokuznetsk State Institute for Postgraduate Medical Education, 654005 Novokuznetsk, Russia.

ORCID-Profile: Anna Ikonnikova, Denis Fedorinov, Dmitry Gryadunov, Rustam Heydarov, Vladimir Mikhailovich, Marina Emelyanova, Vladimir Lyadov

Förderung

  • The Ministry of Science and Higher Education of the Russian Federation
  • Ministry of Science and Higher Education of the Russian Federation to the EIMB Center for Precision Genome Editing and Genetic Technologies for Biomedicine und…

Zitieren

APA

Ikonnikova, A., Fedorinov, D., Gryadunov, D., Heydarov, R., Lyadova, M., Moskalenko, A., Mikhailovich, V., Emelyanova, M., & Lyadov, V. (2024). MIR27A Gene Polymorphism Modifies the Effect of Common DPYD Gene Variants on Severe Toxicity in Patients with Gastrointestinal Tumors Treated with Fluoropyrimidine-Based Anticancer Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158503

Vancouver

Ikonnikova A, Fedorinov D, Gryadunov D, Heydarov R, Lyadova M, Moskalenko A, et al. MIR27A Gene Polymorphism Modifies the Effect of Common DPYD Gene Variants on Severe Toxicity in Patients with Gastrointestinal Tumors Treated with Fluoropyrimidine-Based Anticancer Therapy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158503

BibTeX
@article{Ikonnikova2024,
  author = {Ikonnikova, Anna and Fedorinov, Denis and Gryadunov, Dmitry and Heydarov, Rustam and Lyadova, Marina and Moskalenko, Alexey and Mikhailovich, Vladimir and Emelyanova, Marina and Lyadov, Vladimir},
  title = {MIR27A Gene Polymorphism Modifies the Effect of Common DPYD Gene Variants on Severe Toxicity in Patients with Gastrointestinal Tumors Treated with Fluoropyrimidine-Based Anticancer Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25158503}
}
Kostenlos starten →